Advanced Parenteral Drug Delivery Devices Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

CHAPTER 1. Industry Overview of Advanced Parenteral Drug Delivery Devices Market

1.1. Definition and Scope

1.1.1. Definition of Advanced Parenteral Drug Delivery Devices

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Advanced Parenteral Drug Delivery Devices Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Advanced Parenteral Drug Delivery Devices Market By Product Type 

1.2.3. Advanced Parenteral Drug Delivery Devices Market By Application

1.2.4. Advanced Parenteral Drug Delivery Devices Market By End-User

1.2.5. Advanced Parenteral Drug Delivery Devices Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Advanced Parenteral Drug Delivery Devices Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Advanced Parenteral Drug Delivery Devices Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2023

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023

4.2. R&D Status of Major Manufacturers in 2023

CHAPTER 5. Advanced Parenteral Drug Delivery Devices Market By Product Type

5.1. Introduction

5.2. Advanced Parenteral Drug Delivery Devices Revenue By Product Type

5.2.1. Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast, By Product Type, 2020-2032

5.2.2. IV Catheters

5.2.2.1. IV Catheters Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3. Prefillable Syringes

5.2.3.1. Prefillable Syringes Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4. Hypodermic Syringes

5.2.4.1. Hypodermic Syringes Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5. Injectors Cartridges

5.2.5.1. Injectors Cartridges Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.6. Others

5.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 6. Advanced Parenteral Drug Delivery Devices Market By Application

6.1. Introduction

6.2. Advanced Parenteral Drug Delivery Devices Revenue By Application

6.2.1. Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast, By Application, 2020-2032

6.2.2. Hormones and Related Agents

6.2.2.1. Hormones and Related Agents Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3. Anti-infective Agents

6.2.3.1. Anti-infective Agents Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.4. Genito-urinary Agents

6.2.4.1. Genito-urinary Agents Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.5. Respiratory Agents

6.2.5.1. Respiratory Agents Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.6. Cardiovascular Agents

6.2.6.1. Cardiovascular Agents Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.7. Gastrointestinal Agents

6.2.7.1. Gastrointestinal Agents Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.8. Nutritional Agents

6.2.8.1. Nutritional Agents Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.9. Central Nervous System Agents

6.2.9.1. Central Nervous System Agents Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.10. Others

6.2.10.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 7. Advanced Parenteral Drug Delivery Devices Market By End-User

7.1. Introduction

7.2. Advanced Parenteral Drug Delivery Devices Revenue By End-User

7.2.1. Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast, By End-User, 2020-2032

7.2.2. Ambulatory Surgical Centers

7.2.2.1. Ambulatory Surgical Centers Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3. Hospitals

7.2.3.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.4. Clinics

7.2.4.1. Clinics Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.5. Diagnostic Centers

7.2.5.1. Diagnostic Centers Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.6. Others

7.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 8. North America Advanced Parenteral Drug Delivery Devices Market By Country 

8.1. North America Advanced Parenteral Drug Delivery Devices Market Overview

8.2. U.S.

8.2.1. U.S. Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

8.2.2. U.S. Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

8.2.3. U.S. Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

8.3. Canada

8.3.1. Canada Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

8.3.2. Canada Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

8.3.3. Canada Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

8.4. North America PEST Analysis

CHAPTER 9. Europe Advanced Parenteral Drug Delivery Devices Market By Country

9.1. Europe Advanced Parenteral Drug Delivery Devices Market Overview

9.2. U.K.

9.2.1. U.K. Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

9.2.2. U.K. Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

9.2.3. U.K. Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

9.3. Germany

9.3.1. Germany Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

9.3.2. Germany Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

9.3.3. Germany Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

9.4. France

9.4.1. France Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

9.4.2. France Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

9.4.3. France Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

9.5. Spain

9.5.1. Spain Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

9.5.2. Spain Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

9.5.3. Spain Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

9.6.2. Rest of Europe Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

9.6.3. Rest of Europe Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Advanced Parenteral Drug Delivery Devices Market By Country

10.1. Asia Pacific Advanced Parenteral Drug Delivery Devices Market Overview

10.2. China

10.2.1. China Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

10.2.2. China Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

10.2.3. China Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

10.3. Japan

10.3.1. Japan Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

10.3.2. Japan Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

10.3.3. Japan Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

10.4. India

10.4.1. India Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

10.4.2. India Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

10.4.3. India Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

10.5. Australia

10.5.1. Australia Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

10.5.2. Australia Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

10.5.3. Australia Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

10.6. South Korea

10.6.1. South Korea Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

10.6.2. South Korea Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

10.6.3. South Korea Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

10.7.2. Rest of Asia-Pacific Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

10.7.3. Rest of Asia-Pacific Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

10.8. Asia Pacific PEST Analysis

CHAPTER 11. Latin America Advanced Parenteral Drug Delivery Devices Market By Country

11.1. Latin America Advanced Parenteral Drug Delivery Devices Market Overview

11.2. Brazil

11.2.1. Brazil Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

11.2.2. Brazil Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

11.2.3. Brazil Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

11.3. Mexico

11.3.1. Mexico Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

11.3.2. Mexico Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

11.3.3. Mexico Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

11.4.2. Rest of Latin America Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

11.4.3. Rest of Latin America Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Advanced Parenteral Drug Delivery Devices Market By Country 

12.1. Middle East & Africa Advanced Parenteral Drug Delivery Devices Market Overview

12.2. GCC

12.2.1. GCC Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

12.2.2. GCC Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

12.2.3. GCC Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

12.3. South Africa

12.3.1. South Africa Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

12.3.2. South Africa Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

12.3.3. South Africa Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Product Type, 2020-2032

12.4.2. Rest of Middle East & Africa Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By Application, 2020-2032

12.4.3. Rest of Middle East & Africa Advanced Parenteral Drug Delivery Devices Revenue (USD Million) and Forecast By End-User, 2020-2032

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Advanced Parenteral Drug Delivery Devices Market

13.1. Advanced Parenteral Drug Delivery Devices Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Advanced Parenteral Drug Delivery Devices Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. Company Profile

14.1. Novartis

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Million), 2023

14.1.3.2. Novartis 2023 Advanced Parenteral Drug Delivery Devices Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Roche

14.3. GSK

14.4. Amgen

14.5. Bristol-Myers Squibb

14.6. Boston Scientific

14.7. Abbott Laboratories

14.8. Pfizer

14.9. BD

14.10. AstraZeneca